Zanamivir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk m (→External links) |
imported>David E. Volk (Chem infobox) |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
[[Image:Zanamivir structure.jpg| | |||
{{Chem infobox | |||
|align=right | |||
|image=[[Image:Zanamivir structure.jpg|center|thumb|250px]] | |||
|width=250px | |||
|molname=zanamivir | |||
|synonyms= Relenza® | |||
|molformula= C<sub>12</sub>H<sub>20</sub>N<sub>4</sub>O<sub>7</sub> | |||
|molmass=332.3098 | |||
|uses=influenza A & B | |||
|properties=neuraminidase inhibitor | |||
|hazards=see drug interactions | |||
|iupac= see chemistry section | |||
|casnumber=139110-80-8 | |||
}} | |||
'''Zanamivir''' is a guanido-neuraminic acid that is a [[neuraminidase]] inhibitor used as an [[antiviral drug]] to treat [[influenza]] A and B. | '''Zanamivir''' is a guanido-neuraminic acid that is a [[neuraminidase]] inhibitor used as an [[antiviral drug]] to treat [[influenza]] A and B. | ||
Revision as of 15:38, 26 March 2008
|
| |||||||
| zanamivir | |||||||
| |||||||
| Uses: | influenza A & B | ||||||
| Properties: | neuraminidase inhibitor | ||||||
| Hazards: | see drug interactions | ||||||
| |||||||
Zanamivir is a guanido-neuraminic acid that is a neuraminidase inhibitor used as an antiviral drug to treat influenza A and B.
Its IUPAC chemical name is (4S,5R,6R)-5-acetamido-4-(diaminomethylideneamino)-6-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid and its chemical formula is C12H20N4O7.
Brand names
- GANA
- GNA
- Relenza (GlaxoSmithKline)
- ZMR
- Zanamavir
External links
- Zanamivir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank